B Kuriya1, C K Cheng, H M Chen, V P Bykerk. 1. Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Wolf and Lebovic Building, 60 Murray Street, Box 11, 2nd floor, Toronto, Ontario M5T 3L9, Canada. bindee.kuriya@gmail.com
Abstract
OBJECTIVE: To validate a model which predicts progression from undifferentiated arthritis (UA) to RA, in a Canadian UA cohort. METHODS: The prediction rule, comprising variables which are scored from 0 to 13, with higher scores reflecting an increased risk of RA, was applied to baseline characteristics of all patients with UA. Progression to RA was determined at 6 months. RESULTS: 105 patients were identified. By 6 months, 80 (76%) had developed RA while 25 (24%) had developed another diagnosis. Number of tender and swollen joints, rheumatoid factor positivity, anti-cyclic citrullinated peptide positivity, poor functional status and high disease activity were associated with development of RA (p<0.01). Median prediction score was 8.0 for progressors, 5.0 for non-progressors. With these cut-off points, 18 (72%) patients with scores < or =5 did not develop RA, while 35 (97%) with scores > or =8 did develop RA. CONCLUSIONS: High scores in our cohort predicted those who progressed to RA by 6 months. Baseline scores > or =8 corresponded with higher rates of progression.
OBJECTIVE: To validate a model which predicts progression from undifferentiated arthritis (UA) to RA, in a Canadian UA cohort. METHODS: The prediction rule, comprising variables which are scored from 0 to 13, with higher scores reflecting an increased risk of RA, was applied to baseline characteristics of all patients with UA. Progression to RA was determined at 6 months. RESULTS: 105 patients were identified. By 6 months, 80 (76%) had developed RA while 25 (24%) had developed another diagnosis. Number of tender and swollen joints, rheumatoid factor positivity, anti-cyclic citrullinated peptide positivity, poor functional status and high disease activity were associated with development of RA (p<0.01). Median prediction score was 8.0 for progressors, 5.0 for non-progressors. With these cut-off points, 18 (72%) patients with scores < or =5 did not develop RA, while 35 (97%) with scores > or =8 did develop RA. CONCLUSIONS: High scores in our cohort predicted those who progressed to RA by 6 months. Baseline scores > or =8 corresponded with higher rates of progression.
Authors: Khalid Almutairi; Charles Inderjeeth; David B Preen; Helen Keen; Katrina Rogers; Johannes Nossent Journal: Rheumatol Int Date: 2021-02-23 Impact factor: 2.631
Authors: P Machado; I Castrejon; W Katchamart; R Koevoets; B Kuriya; M Schoels; L Silva-Fernández; K Thevissen; W Vercoutere; E Villeneuve; D Aletaha; L Carmona; R Landewé; D van der Heijde; J W J Bijlsma; V Bykerk; H Canhão; A I Catrina; P Durez; C J Edwards; M D Mjaavatten; B F Leeb; B Losada; E M Martín-Mola; P Martinez-Osuna; C Montecucco; U Müller-Ladner; M Østergaard; B Sheane; R M Xavier; J Zochling; C Bombardier Journal: Ann Rheum Dis Date: 2010-08-19 Impact factor: 19.103
Authors: Celina Alves; Jolanda Jacoba Luime; Derkjen van Zeben; Anne-Margriet Huisman; Angelique Elisabeth Adriana Maria Weel; Pieternella Johanna Barendregt; Johanna Maria Wilhelmina Hazes Journal: Ann Rheum Dis Date: 2011-05-27 Impact factor: 19.103
Authors: Mohamed M Thabet; Thomas W J Huizinga; Désirée M van der Heijde; Annette H M van der Helm-van Mil Journal: Arthritis Res Ther Date: 2009-10-15 Impact factor: 5.156
Authors: Carole L Galligan; Janet C Siebert; Katherine A Siminovitch; Edward C Keystone; Vivian Bykerk; Omar D Perez; Eleanor N Fish Journal: PLoS One Date: 2009-08-20 Impact factor: 3.240